EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Chester J Kao, Soren Charmsaz, Stephanie L Alden, Madelena Brancati, Howard L Li, Aanika Balaji, Kabeer Munjal, Kathryn Howe, Sarah Mitchell, James Leatherman, Ervin Griffin, Mari Nakazawa und 31 weitere

Journal of Clinical Investigation · 15.10.2024 · 134 (20)

DOI: 10.1172/jci176567 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 29.08.2024. Verfasst von Chester J Kao und 42 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Neoplasms, Th17 Cells, Th2 Cells. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDImmune-related adverse events (irAEs) and their associated morbidity/mortality are a key concern for patients receiving immune checkpoint inhibitors (ICIs). Prospective evaluation of the drivers of irAEs in a diverse pan-tumor cohort is needed to identify patients at greatest risk and to develop rational treatment and interception strategies.METHODSIn an observational study, we prospectively collected blood samples and performed regular clinical evaluations for irAEs in patients receiving ICI therapy as standard of care for solid tumors. We performed in-parallel analysis of cytokines by Luminex immunoassay and circulating immune cells by cytometry by time-of-flight (CyTOF) at baseline and on treatment to investigate mechanisms of irAEs.RESULTSWe enrolled 111 patients, of whom 40.5% developed a symptomatic irAE (grade ≥ 2). Development of a grade ≥ 2 irAE was positively associated with the use of combination ICI and a history of an autoimmune disorder. Early changes in T helper 17 (Th17) (IL-6, IL-17f), type 2 (IL-5, IL-13, IL-25), and type 1 (TNF-α) cytokine signatures and congruent on-treatment expansions of Th17 and Th2 effector memory (Th2EM) T cell populations in peripheral blood were positively associated with the development of grade ≥2 irAEs. IL-6 levels were also associated with inferior cancer-specific survival and overall survival.CONCLUSIONSIn a diverse, prospective pan-tumor cohort, Th17 and Th2 skewing during early ICI treatment was associated with the development of clinically relevant irAEs but not antitumor responses, providing possible targets for monitoring and therapeutic interventions.FUNDINGJohns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, the NCI SPORE in Gastrointestinal Cancers (P50 CA062924), NCI grant (R50CA243627 to LD), the NIH Center Core Grant (P30 CA006973), Swim Across America (to MY), NIAMS (K23AR075872 to LC), and imCORE-Genentech grant 137515 (to Johns Hopkins Medicine on behalf of MY).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTh17 CellsTh2 CellsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedImmune Checkpoint InhibitorsImmunotherapyProspective Studies

Stichwörter der Autor:innen

CytokinesImmunotherapyOncologyT cells

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland, USA.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Convergence Institute and.
  • Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Beaumont Hospital, Dublin, Ireland.

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • NIH HHS
  • NCI Specialized Program of Research Excellence in Gastrointestinal Cancers
  • NIH Center Core
  • Bloomberg-Kimmel Institute for Cancer Immunotherapy
  • Swim Across America
  • NIAMS

Zitieren

APA

Kao, C. J., Charmsaz, S., Alden, S. L., Brancati, M., Li, H. L., Balaji, A., Munjal, K., Howe, K., Mitchell, S., Leatherman, J., Griffin, E., Nakazawa, M., Tsai, H. L., Danilova, L., Thoburn, C., Gizzi, J., Gross, N. E., Hernandez, A., Coyne, E. M., …, & Yarchoan, M. (2024). Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures. Journal of Clinical Investigation, 134(20). https://doi.org/10.1172/jci176567

Vancouver

Kao CJ, Charmsaz S, Alden SL, Brancati M, Li HL, Balaji A, et al. Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures. Journal of Clinical Investigation. 2024;134(20). doi:10.1172/jci176567

BibTeX
@article{Kao2024,
  author = {Kao, Chester J and Charmsaz, Soren and Alden, Stephanie L and Brancati, Madelena and Li, Howard L and Balaji, Aanika and Munjal, Kabeer and Howe, Kathryn and Mitchell, Sarah and Leatherman, James and Griffin, Ervin and Nakazawa, Mari and Tsai, Hua-Ling and Danilova, Ludmila and Thoburn, Chris and Gizzi, Jennifer and Gross, Nicole E and Hernandez, Alexei and Coyne, Erin M and Shin, Sarah M and Babu, Jayalaxmi Suresh and Apostol, George W and Durham, Jennifer and Christmas, Brian J and Konig, Maximilian F and Lipson, Evan J and Naidoo, Jarushka and Cappelli, Laura C and Pabani, Aliyah and Ged, Yasser and Baretti, Marina and Brahmer, Julie and Hoffman-Censits, Jean and Seiwert, Tanguy Y and Garonce-Hediger, Rachel and Guha, Aditi and Bansal, Sanjay and Tang, Laura and Jaffee, Elizabeth M and Chandler, G Scott and Mohindra, Rajat and Ho, Won Jin and Yarchoan, Mark},
  title = {Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {20},
  doi = {10.1172/jci176567}
}
Kostenlos starten →